Oragenics, Inc.

Latest News

Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients

On the Cutting Edge

We are developing medical technologies that solve unmet clinical needs and have a substantial market opportunity

Learn More

Sign up for email updates

Be the first to receive breaking news

Sign Up

Investors Presentation

View our latest Corporate Presentation

View presentation ยป
Oragenics Pesentation
NYSE American OGEN
Price Loading...
Change Loading...
Day Range Loading...
52 Wk Range Loading...

Last Updated: